Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001742084-26-000003

CEO sold 5,124 shares at $3.04 ($15,563)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

O'Neill Gilmore Neil · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-03 Sale : show line 1 in the form 10b5-1 −5,124 $3.04 $15,563 243,189 D
Open-market sales · 5,124 sh · avg $3.04 · $15,563
Loading xslF345X06/wk-form4_1788553359.xml…